Search | WHO COVID-19 Research Database

About the source and consequences of ¹⁸F-FDG brain PET hypometabolism in short and long COVID-19.

Fontana, Igor C; Souza, Débora Guerini; Pellerin, Luc; Souza, Diogo O; Zimmer, Eduardo R.

Eur J Nucl Med Mol Imaging ; 48(9): 2674-2675, 2021 08.

Article in English | MEDLINE | ID: covidwho-1298553

Subject(s)

COVID-19 , Fluorodeoxyglucose F18 , Brain/diagnostic imaging , COVID-19/complications , Humans , Positron-Emission Tomography , SARS-CoV-2 , Post-Acute COVID-19 Syndrome

PET Imaging as a Tool for Assessing COVID-19 Brain Changes.

Fontana, Igor C; Bongarzone, Salvatore; Gee, Antony; Souza, Diogo O; Zimmer, Eduardo R.

Trends Neurosci ; 43(12): 935-938, 2020 12.

Article in English | MEDLINE | ID: covidwho-885448

ABSTRACT

A substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography (PET) applications that could advance current understanding of CNS pathophysiological alterations associated with SARS-CoV-2 infection.

Subject(s)

Brain/diagnostic imaging , COVID-19/diagnostic imaging , Neuroimaging/methods , Positron-Emission Tomography/methods , Brain/metabolism , Brain/pathology , COVID-19/complications , COVID-19/physiopathology , Humans

Subject(s)

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL